Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool as read-only, idempotent, and non-destructive, and the description adds a meaningful specific guarantee: it never creates a cart. It also discloses what data sources it uses (current public prices, biomarker counts, reporting value, individual-test availability), giving the agent extra confidence beyond the structured hints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two short sentences, front-loads the core action, and every clause adds information. It avoids restating annotation fields verbatim, and the safety note is a worthwhile addition.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a parameterless read-only comparison tool with an output schema and strong annotations, the description covers the important use context and safety posture. It is slightly incomplete only in not distinguishing its scope from the similarly named compare_blood_testing_services sibling.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The tool has zero parameters, so the baseline is 4; there is no schema gap to compensate. The description appropriately clarifies what the fixed comparison will include, which is sufficient for a no-input tool.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies a specific action ('Compares'), the exact package set (Essential, Advanced, and Max), and the comparison dimensions (prices, biomarker counts, reporting value, availability). It does not explicitly contrast itself with the similar sibling compare_blood_testing_services, which prevents a 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

No guidance is given for when to select this tool over siblings such as compare_blood_testing_services or get_lab_package. The only usage-related statement is a negative safety note ('never creates a cart'), which does not help choose between alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.